{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:20:49Z","timestamp":1767849649490,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA17007"],"award-info":[{"award-number":["CA17007"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA64239"],"award-info":[{"award-number":["CA64239"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1016\/s0002-9440(10)63042-8","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T00:03:18Z","timestamp":1296172998000},"page":"1949-1956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Thrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice"],"prefix":"10.1016","volume":"159","author":[{"given":"Jack","family":"Lawler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Min","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Duquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00ebl","family":"Bouck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roderick T.","family":"Bronson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard O.","family":"Hynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9440(10)63042-8_bib1","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1101\/gad.12.19.2973","article-title":"The complexity of p53 modulation: emerging patterns from divergent signals","volume":"12","author":"Giaccia","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/S0002-9440(10)63042-8_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/356215a0","article-title":"Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors","volume":"356","author":"Donehower","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S0002-9440(10)63042-8_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","article-title":"Tumor spectrum analysis in p53-mutant mice","volume":"4","author":"Jacks","year":"1994","journal-title":"Curr Biol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1096\/fasebj.7.10.8344491","article-title":"Genetic background alters the spectrum of tumors that develop in p53-deficient mice","volume":"7","author":"Harvey","year":"1993","journal-title":"FASEB J"},{"key":"10.1016\/S0002-9440(10)63042-8_bib5","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/S0959-8049(96)00385-1","article-title":"Tumour suppressor genes and angiogenesis: the role of TP53 in fibroblasts","volume":"32A","author":"Stellmach","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0002-9440(10)63042-8_bib6","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.onc.1200977","article-title":"Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity","volume":"14","author":"Volpert","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/S0002-9440(10)63042-8_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00666034","article-title":"The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression","volume":"36","author":"Volpert","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S0002-9440(10)63042-8_bib8","first-page":"5684","article-title":"Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1","volume":"56","author":"Hsu","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5","article-title":"Analysis of centrosome abnormalities and angiogenesis in epidermal-targeted p53172H mutant and p53-knockout mice after chemical carcinogenesis: evidence for a gain of function","volume":"23","author":"Wang","year":"1998","journal-title":"Mol Carcinog"},{"key":"10.1016\/S0002-9440(10)63042-8_bib10","first-page":"1298","article-title":"Molecular mediators of angiogenesis in bladder cancer","volume":"58","author":"Campbell","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib11","series-title":"The Thrombospondin Gene Family","author":"Adams","year":"1995"},{"key":"10.1016\/S0002-9440(10)63042-8_bib12","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1096\/fasebj.6.14.1426766","article-title":"Thrombospondins: structure and regulation of expression","volume":"6","author":"Bornstein","year":"1992","journal-title":"FASEB J"},{"key":"10.1016\/S0002-9440(10)63042-8_bib13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1096\/fasebj.10.10.8751720","article-title":"Regulation of tumor growth and metastasis by thrombospondin-1","volume":"10","author":"Roberts","year":"1996","journal-title":"FASEB J"},{"key":"10.1016\/S0002-9440(10)63042-8_bib14","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1074\/jbc.270.13.7304","article-title":"Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1","volume":"270","author":"Schultz-Cherry","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0002-9440(10)63042-8_bib15","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0092-8674(00)81460-9","article-title":"Thrombospondin-1 is a major activator of TGF-\u03b21 in vivo","volume":"93","author":"Crawford","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0002-9440(10)63042-8_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1749-6632.1992.tb51598.x","article-title":"Modulation of fibrinolysis by thrombospondin","volume":"667","author":"Mosher","year":"1992","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S0002-9440(10)63042-8_bib17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1042\/bj2890903","article-title":"Characterization of the antiplasmin activity of human thrombospondin-1 in solution","volume":"289","author":"Anonick","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/S0002-9440(10)63042-8_bib18","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1021\/bi00187a021","article-title":"Identification of possible inhibitory reactive centers in thrombospondin 1 that may bind cathepsin G and neutrophil elastase","volume":"33","author":"Hogg","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/S0002-9440(10)63042-8_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0065-230X(08)60862-3","article-title":"How tumors become angiogenic","volume":"69","author":"Bouck","year":"1996","journal-title":"Adv Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/S0002-9440(10)63042-8_bib21","series-title":"Antiangiogenic Agents in Cancer Therapy","first-page":"185","article-title":"Thrombospondin as an inhibitor of angiogenesis","author":"Dawson","year":"1999"},{"key":"10.1016\/S0002-9440(10)63042-8_bib22","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1073\/pnas.89.7.3040","article-title":"Heparin- and sulfatide-binding peptides from the type 1 repeats of human thrombospondin promote melanoma cell adhesion","volume":"89","author":"Guo","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)63042-8_bib23","first-page":"3154","article-title":"Differential roles of protein kinase C and pertussis toxin-sensitive G-proteins in modulation of melanoma cell proliferation and motility by thrombospondin-1","volume":"58","author":"Guo","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib24","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1083\/jcb.105.5.2409","article-title":"Thrombospondin-induced tumor cell migration: heptotaxis and chemotaxis are mediated by different molecular domains","volume":"105","author":"Taraboletti","year":"1987","journal-title":"J Cell Biol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib25","first-page":"6624","article-title":"A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin","volume":"87","author":"Good","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0002-9440(10)63042-8_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1083\/jcb.120.2.513","article-title":"Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain","volume":"120","author":"Tuszynski","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1083\/jcb.122.2.497","article-title":"Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity","volume":"122","author":"Tolsma","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib28","first-page":"1735","article-title":"Thrombospondin 1 and type 1 repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells","volume":"57","author":"Guo","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1399-3011.1997.tb01187.x","article-title":"Antiproliferative and antitumor activities of D-reversed peptides derived from the second type 1 repeat of thrombospondin-1","volume":"50","author":"Guo","year":"1997","journal-title":"J Peptide Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1083\/jcb.138.3.707","article-title":"CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells","volume":"138","author":"Dawson","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/71517","article-title":"Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1","volume":"6","author":"Jimenez","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9440(10)63042-8_bib32","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood.V97.6.1689","article-title":"Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth","volume":"97","author":"Miao","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S0002-9440(10)63042-8_bib33","first-page":"396","article-title":"Thrombospondin-1 and -2 messenger RNA expression in normal, benign and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis and fibroblastic desmoplasia","volume":"57","author":"Bertin","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jnci\/89.3.219","article-title":"Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis and tumor progression","volume":"89","author":"Grossfeld","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0002-9440(10)63042-8_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s004280050268","article-title":"Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells","volume":"433","author":"Tokunaga","year":"1998","journal-title":"Virchows Arch"},{"key":"10.1016\/S0002-9440(10)63042-8_bib36","first-page":"1041","article-title":"Vascular stroma formation in carcinoma of the breast","volume":"5","author":"Brown","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib37","first-page":"678","article-title":"Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1","volume":"143","author":"DiPietro","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib38","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.280.5366.1036","article-title":"Landscaping the cancer terrain","volume":"280","author":"Kinzler","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0002-9440(10)63042-8_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/S0002-9440(10)63042-8_bib40","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1073\/pnas.95.11.6343","article-title":"A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1","volume":"95","author":"Volpert","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)63042-8_bib41","first-page":"51","article-title":"Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells","volume":"77","author":"Castle","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/S0002-9440(10)63042-8_bib42","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1073\/pnas.92.15.6788","article-title":"Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis","volume":"92","author":"Sheibani","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)63042-8_bib43","first-page":"6504","article-title":"Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential and angiogenesis","volume":"54","author":"Weinstat-Saslow","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib44","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1073\/pnas.96.5.2065","article-title":"Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vasculature","volume":"96","author":"Bleuel","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)63042-8_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-9440(10)65140-1","article-title":"Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas","volume":"155","author":"Streit","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1172\/JCI1684","article-title":"Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia","volume":"101","author":"Lawler","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9440(10)63042-8_bib47","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1093\/nar\/19.15.4293","article-title":"Simplified mammalian DNA isolation procedure","volume":"19","author":"Laird","year":"1991","journal-title":"Nucl Acids Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib48","series-title":"Survival Analysis","author":"Miller","year":"1981"},{"key":"10.1016\/S0002-9440(10)63042-8_bib49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2307\/2684555","article-title":"Statools: statistical utility programs","volume":"40","author":"Dallal","year":"1986","journal-title":"Am Stat"},{"key":"10.1016\/S0002-9440(10)63042-8_bib50","first-page":"279","article-title":"Detection of loss of heterozygosity in formalin-fixed paraffin-embedded tumor specimens by the polymerase chain reaction","volume":"138","author":"Bianchi","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib51","series-title":"Molecular Cloning: A Laboratory Manual","first-page":"382","author":"Maniatis","year":"1982"},{"key":"10.1016\/S0002-9440(10)63042-8_bib52","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/aja.1001930408","article-title":"Colocalization of thrombospondin and syndecan during murine development","volume":"193","author":"Corless","year":"1992","journal-title":"Dev Dyn"},{"key":"10.1016\/S0002-9440(10)63042-8_bib53","first-page":"848","article-title":"A test of the role of \u03b15 integrin\/fibronectin interactions in tumorigenesis","volume":"58","author":"Taverna","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib54","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1093\/emboj\/17.16.4657","article-title":"Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation","volume":"17","author":"Venkatachalam","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/S0002-9440(10)63042-8_bib55","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/342705a0","article-title":"Mutations in the p53 gene occur in diverse human tumor types","volume":"342","author":"Nigro","year":"1989","journal-title":"Nature"},{"key":"10.1016\/S0002-9440(10)63042-8_bib56","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1073\/pnas.87.15.5863","article-title":"Mechanisms of p53 loss in human sarcomas","volume":"87","author":"Mulligan","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)63042-8_bib57","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1073\/pnas.88.11.5006","article-title":"Genetic basis for p53 overexpression in human breast cancer","volume":"88","author":"Davidoff","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)63042-8_bib58","first-page":"3918","article-title":"p53 mutations occur in aggressive breast cancer","volume":"52","author":"Mazars","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib59","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1093\/emboj\/20.11.2631","article-title":"Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism","volume":"20","author":"Hawighorst","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/S0002-9440(10)63042-8_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1525-1500.1998.0oa18.x","article-title":"Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma","volume":"22","author":"Grant","year":"1998","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/S0002-9440(10)63042-8_bib61","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/S0959-8049(96)00401-7","article-title":"Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models","volume":"32A","author":"Hanahan","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0002-9440(10)63042-8_bib62","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1073\/pnas.93.5.2002","article-title":"Anti-angiogenic therapy of transgenic mice impairs de novo tumor growth","volume":"93","author":"Parangi","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)63042-8_bib63","first-page":"3379","article-title":"Transforming growth factor \u03b21 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis","volume":"59","author":"Engle","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S0002-9440(10)63042-8_bib64","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nm0798-802","article-title":"Transforming growth factor-\u03b21 is a new form of tumor suppressor with true haploid insufficiency","volume":"4","author":"Tang","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9440(10)63042-8_bib65","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<284::AID-PATH94>3.0.CO;2-Z","article-title":"Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas","volume":"185","author":"Franchi","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib66","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2230::AID-CNCR3>3.0.CO;2-Y","article-title":"Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-Beta3 is related to disease progression","volume":"80","author":"Kloen","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S0002-9440(10)63042-8_bib67","first-page":"1635","article-title":"Transforming growth factor \u03b21 (TGF \u03b21) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF \u03b21 antisense expression plasmid","volume":"6","author":"Huang","year":"1995","journal-title":"Cell Growth Differ"},{"key":"10.1016\/S0002-9440(10)63042-8_bib68","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00001622-199403000-00015","article-title":"Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma","volume":"6","author":"Lu","year":"1994","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/S0002-9440(10)63042-8_bib69","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/endo.139.2.5907","article-title":"A proliferative effect of transforming growth factor-\u03b21 on a human prostate cancer cell line, TSU-Pr1","volume":"139","author":"Lamm","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/S0002-9440(10)63042-8_bib70","first-page":"2210","article-title":"Transforming growth factor \u03b21 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma","volume":"59","author":"Ananth","year":"1999","journal-title":"Cancer Res"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010630428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010630428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:18:29Z","timestamp":1757600309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010630428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0002944010630428"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9440(10)63042-8","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9440(10)63042-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}